These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6611584)

  • 1. Prolonged red cell survival following in vitro treatment with potassium cyanate. A study in patients undergoing open-heart surgery.
    Roberts D; Bake B; William-Olsson G
    Scand J Thorac Cardiovasc Surg; 1984; 18(2):111-4. PubMed ID: 6611584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved red cell survival in patients with chronic subclinical haemolysis due to artificial heart valve. Observations after in vitro treatment of the cells with potassium cyanate.
    Roberts D; Bake B; William-Olsson G
    Scand J Thorac Cardiovasc Surg; 1984; 18(2):115-8. PubMed ID: 6463625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved red blood cell survival after cardiac operations with administration of urea during cardiopulmonary bypass.
    Roberts D; Bake B; William-Olsson G
    J Thorac Cardiovasc Surg; 1985 Jan; 89(1):107-14. PubMed ID: 3871235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aortic and mitral valve surgery on the beating heart is lowering cardiopulmonary bypass and aortic cross clamp time.
    Gersak B; Sutlic Z
    Heart Surg Forum; 2002; 5(2):182-6. PubMed ID: 12125670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autologous survival of cyanate-treated cryopreserved sickle erythrocytes.
    Castro O; Rana SR; Poillon WN
    Am J Hematol; 1986 Apr; 21(4):409-13. PubMed ID: 3953559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postoperative delirium and short-term cognitive dysfunction occur more frequently in patients undergoing valve surgery with or without coronary artery bypass graft surgery compared with coronary artery bypass graft surgery alone: results of a pilot study.
    Hudetz JA; Iqbal Z; Gandhi SD; Patterson KM; Byrne AJ; Pagel PS
    J Cardiothorac Vasc Anesth; 2011 Oct; 25(5):811-6. PubMed ID: 20655248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Octogenarians undergoing coronary artery bypass graft surgery: resource utilization, postoperative mortality, and morbidity.
    Scott BH; Seifert FC; Grimson R; Glass PS
    J Cardiothorac Vasc Anesth; 2005 Oct; 19(5):583-8. PubMed ID: 16202890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of urea on red cell deformability during cardiopulmonary bypass.
    Yamaguchi H; Allers M; Roberts D
    Scand J Thorac Cardiovasc Surg; 1984; 18(2):119-22. PubMed ID: 6611585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The metabolic effects of fresh versus old stored blood in the priming of cardiopulmonary bypass solution for pediatric patients.
    Keidan I; Amir G; Mandel M; Mishali D
    J Thorac Cardiovasc Surg; 2004 Apr; 127(4):949-52. PubMed ID: 15052188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased life span and membrane damage of carbamylated erythrocytes in vitro.
    Lane TA; Burka ER
    Blood; 1976 Jun; 47(6):909-17. PubMed ID: 1276471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of complement activation by pexelizumab reduces death in patients undergoing combined aortic valve replacement and coronary artery bypass surgery.
    Carrier M; Ménasché P; Levy JH; Newman MF; Taylor KM; Haverich A; Chen JC; Shernan SK; Van de Werf F; van der Laan M; Todaro TG; Adams PX; Verrier ED
    J Thorac Cardiovasc Surg; 2006 Feb; 131(2):352-6. PubMed ID: 16434264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 14C cyanate as a tag for red cell survival in normal and uremic man.
    Eschbach JW; Korn D; Finch CA
    J Lab Clin Med; 1977 Apr; 89(4):823-8. PubMed ID: 845482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aortic valve replacement in patients with previous coronary artery bypass grafting: 10-year experience.
    Vohra HA; Pousios D; Whistance RN; Haw MP; Barlow CW; Ohri SK; Livesey SA; Tsang GM
    Eur J Cardiothorac Surg; 2012 Mar; 41(3):e1-6. PubMed ID: 22219478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Terminal complement blockade with pexelizumab during coronary artery bypass graft surgery requiring cardiopulmonary bypass: a randomized trial.
    Verrier ED; Shernan SK; Taylor KM; Van de Werf F; Newman MF; Chen JC; Carrier M; Haverich A; Malloy KJ; Adams PX; Todaro TG; Mojcik CF; Rollins SA; Levy JH;
    JAMA; 2004 May; 291(19):2319-27. PubMed ID: 15150203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor release following coronary artery bypass surgery: extracorporeal circulation versus 'beating heart' surgery.
    Burton PB; Owen VJ; Hafizi S; Barton PJ; Carr-White G; Koh T; De Souza A; Yacoub MH; Pepper JR
    Eur Heart J; 2000 Oct; 21(20):1708-13. PubMed ID: 11032698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lowest safe hematocrit level on cardiopulmonary bypass in patients undergoing coronary artery bypass grafting.
    DiMarco A; Vélez H; SoItero E; Magraner M; Bredy R
    Bol Asoc Med P R; 2011; 103(2):25-9. PubMed ID: 22111467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurocognitive function in patients undergoing coronary artery bypass graft surgery with cardiopulmonary bypass: the effect of two different rewarming strategies.
    Sahu B; Chauhan S; Kiran U; Bisoi A; Lakshmy R; Selvaraj T; Nehra A
    J Cardiothorac Vasc Anesth; 2009 Feb; 23(1):14-21. PubMed ID: 18834816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfusion requirements in elective cardiopulmonary bypass surgery patients: predictive value of Multiplate and Thromboelastography (TEG) Platelet Mapping Assay.
    Sivapalan P; Bäck AC; Ostrowski SR; Ravn HB; Johansson PI
    Scand J Clin Lab Invest; 2017 Sep; 77(5):345-351. PubMed ID: 28537454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Earlier recovery with beating-heart surgery: a comparison of 300 patients undergoing conventional versus off-pump coronary artery bypass graft surgery.
    Lee JH; Capdeville M; Marsh D; Abdelhady K; Poostizadeh A; Murrell H
    J Cardiothorac Vasc Anesth; 2002 Apr; 16(2):139-43. PubMed ID: 11957160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doxycycline reduces cardiac matrix metalloproteinase-2 activity but does not ameliorate myocardial dysfunction during reperfusion in coronary artery bypass patients undergoing cardiopulmonary bypass.
    Schulze CJ; Castro MM; Kandasamy AD; Cena J; Bryden C; Wang SH; Koshal A; Tsuyuki RT; Finegan BA; Schulz R
    Crit Care Med; 2013 Nov; 41(11):2512-20. PubMed ID: 23928836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.